These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Community-acquired acute meningitis and encephalitis: a narrative review. Beaman MH Med J Aust; 2018 Nov; 209(10):449-454. PubMed ID: 30309300 [TBL] [Abstract][Full Text] [Related]
5. Direct and indirect effects of the 13-valent pneumococcal conjugate vaccine administered to infants and young children. Esposito S; Principi N; Future Microbiol; 2015; 10(10):1599-607. PubMed ID: 26439470 [TBL] [Abstract][Full Text] [Related]
6. Impact of pneumococcal conjugate vaccine on the prevention of invasive pneumococcal diseases. Bricks LF; Berezin E J Pediatr (Rio J); 2006 Jul; 82(3 Suppl):S67-74. PubMed ID: 16721440 [TBL] [Abstract][Full Text] [Related]
7. [International studies again confirm the positive effects of pneumococcal vaccinations]. Bilic S Kinderkrankenschwester; 2006 Aug; 25(8):322-3. PubMed ID: 16937827 [No Abstract] [Full Text] [Related]
8. [Therapeutic approaches in children immunized with vaccine Prevenar]. Cohen R; Aujard Y; Bingen E; Boucherat M; Bourrillon A; Foucaud P; Francois M; Garnier JM; Guillot M; Ovetchkine P; Ployet MJ; Quinet B; Gaudelus J Arch Pediatr; 2002 Jan; 9(1):4-6. PubMed ID: 11865548 [No Abstract] [Full Text] [Related]
9. Impact of infant pneumococcal conjugate vaccination on community acquired pneumonia hospitalization in all ages in the Netherlands. van Deursen AMM; Schurink-Van't Klooster TM; Man WH; van de Kassteele J; van Gageldonk-Lafeber AB; Bruijning-Verhagen PCJL; de Melker HE; Sanders EAM; Knol MJ Vaccine; 2017 Dec; 35(51):7107-7113. PubMed ID: 29146381 [TBL] [Abstract][Full Text] [Related]
10. Pneumococcal vaccines and the prevention of community-acquired pneumonia. Esposito S; Principi N Pulm Pharmacol Ther; 2015 Jun; 32():124-9. PubMed ID: 24607597 [TBL] [Abstract][Full Text] [Related]
11. Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study. Choi YH; Andrews N; Miller E PLoS Med; 2019 Jul; 16(7):e1002845. PubMed ID: 31269018 [TBL] [Abstract][Full Text] [Related]
12. Pneumococcal vaccines: do they prevent infection and how? Posfay-Barbe KM; Wald ER Curr Opin Infect Dis; 2004 Jun; 17(3):177-84. PubMed ID: 15166818 [TBL] [Abstract][Full Text] [Related]
13. Pneumococcal vaccines for older adults: getting the timing right. Campos-Outcalt D J Fam Pract; 2014 Dec; 63(12):730-3. PubMed ID: 25486320 [No Abstract] [Full Text] [Related]
14. Lack of pneumococcal antigenuria in infants immunized with heptavalent pneumococcal conjugate vaccine. Hilal K; Carey R; Challapalli M Pediatr Infect Dis J; 2001 Sep; 20(9):912. PubMed ID: 11734775 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy of the heptavalent pneumococcal vaccine against meningitis, pneumonia and acute otitis media in pediatric age. Theoretical coverage offered by the heptavalent conjugate vaccine in Italy]. Principi N; Esposito S Ann Ig; 2002; 14(6 Suppl 7):21-30. PubMed ID: 12638361 [TBL] [Abstract][Full Text] [Related]
16. A conjugate vaccine for the prevention of pediatric pneumococcal disease. Murray D; Jackson C Mil Med; 2002 Aug; 167(8):671-7. PubMed ID: 12188240 [TBL] [Abstract][Full Text] [Related]
17. Vaccines to Prevent Pneumococcal Community-Acquired Pneumonia. van Werkhoven CH; Huijts SM Clin Chest Med; 2018 Dec; 39(4):733-752. PubMed ID: 30390745 [TBL] [Abstract][Full Text] [Related]
18. From the Centers for Disease Control and Prevention. Decreased availability of pneumococcal conjugate vaccine. JAMA; 2001 Nov; 286(18):2232. PubMed ID: 11757530 [No Abstract] [Full Text] [Related]